EUVIMEDEUVIMED entdecken
Crossref

The OTUD1-Notch2-ICD axis orchestrates allogeneic T cell–mediated graft-versus-host disease

Qiao Cheng, Dong Wang, Xiaoxuan Lai, Yin Liu iD, Yibo Zuo, Wenli Zhang, Lei Lei, Jia Chen, Hong Liu, Ying Wang iD, Haiyan Liu, Hui Zheng iD und 2 weitere

Blood · 23.03.2023 · 141 (12) · 1474-1488

DOI: 10.1182/blood.2022017201 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Blood, erschienen am 23.03.2023. Verfasst von Qiao Cheng und 13 weiteren Autor:innen. Beteiligte Einrichtung: National Clinical Research Center for Hematologic Diseases, Jiangsu Institute of Hematology, The First Affiliated Hospital of Soochow University, Ins…. Hauptthemen laut MEDLINE: Graft vs Host Disease, Hematopoietic Stem Cell Transplantation. Die Arbeit wurde bisher 15-mal zitiert (Crossref) und nennt 42 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Disorders of the ubiquitin-proteasome system (UPS) are known to influence the incidence and mortality of various diseases. It remains largely unknown whether and how the UPS affects the onset and progression of acute graft-verus-host disease (aGVHD) after allogeneic hematopoietic stem cell transplantation (allo-HSCT). This study demonstrated that the deubiquitinase OTUD1 is an essential regulator of aGVHD. Activation of CD4+ T cells after allo-HSCT, elevated the protein levels of OTUD1, which in turn interacted with the Notch2-ICD (NICD) to cleave the ubiquitin of NICD at the K1770 site, thereby inducing NICD protein accumulations in T cells. OTUD1-driven NICD signaling promoted the differentiation and functions of Th1 and Th17 cells and amplified the cascade of aGVHD. Moreover, by screening a FDA-approved drugs library the study identified dapagliflozin as an inhibitor targeting the OTUD1/NICD axis. Dapagliflozin administration significantly prolonged the survival of aGVHD mice. This study characterized a previously unknown role of OTUD1 in T cell–mediated allogeneic responses and provided a promising therapeutic strategy to target OTUD1 for the alleviation of aGVHD.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Graft vs Host DiseaseHematopoietic Stem Cell TransplantationAnimalsMiceAcute DiseaseCD4-Positive T-LymphocytesUbiquitinsBenzhydryl CompoundsGlucosidesUbiquitin-Specific ProteasesReceptor, Notch2

Substanzen

UbiquitinsdapagliflozinBenzhydryl CompoundsGlucosidesOtud1 protein, mouseUbiquitin-Specific ProteasesNotch2 protein, mouseReceptor, Notch2

Autor:innen und Institutionen

  • National Clinical Research Center for Hematologic Diseases, Jiangsu Institute of Hematology, The First Affiliated Hospital of Soochow University, Institute of Blood and Marrow Transplantation, Collaborative Innovation C…
  • Jiangsu Key Laboratory of Infection and Immunity, Institutes of Biology and Medical Sciences, Soochow University, Suzhou, China.
  • Immunology Programme, Life Sciences Institute and Department of Microbiology and Immunology, Yong Loo Lin School of Medicine, National University of Singapore, Singapore.

ORCID-Profile: Yin Liu, Ying Wang, Hui Zheng, Depei Wu

Zitieren

APA

Cheng, Q., Wang, D., Lai, X., Liu, Y., Zuo, Y., Zhang, W., Lei, L., Chen, J., Liu, H., Wang, Y., Liu, H., Zheng, H., Wu, D., & Xu, Y. (2023). The OTUD1-Notch2-ICD axis orchestrates allogeneic T cell–mediated graft-versus-host disease. Blood, 141(12), 1474-1488. https://doi.org/10.1182/blood.2022017201

Vancouver

Cheng Q, Wang D, Lai X, Liu Y, Zuo Y, Zhang W, et al. The OTUD1-Notch2-ICD axis orchestrates allogeneic T cell–mediated graft-versus-host disease. Blood. 2023;141(12):1474-1488. doi:10.1182/blood.2022017201

BibTeX
@article{Cheng2023,
  author = {Cheng, Qiao and Wang, Dong and Lai, Xiaoxuan and Liu, Yin and Zuo, Yibo and Zhang, Wenli and Lei, Lei and Chen, Jia and Liu, Hong and Wang, Ying and Liu, Haiyan and Zheng, Hui and Wu, Depei and Xu, Yang},
  title = {The OTUD1-Notch2-ICD axis orchestrates allogeneic T cell–mediated graft-versus-host disease},
  journal = {Blood},
  year = {2023},
  volume = {141},
  number = {12},
  pages = {1474--1488},
  doi = {10.1182/blood.2022017201}
}
Kostenlos starten →